Skip to main content

Main menu

  • HOME
  • ONLINE FIRST
  • CURRENT ISSUE
  • ALL ISSUES
  • AUTHORS & REVIEWERS
  • SUBSCRIBE
  • BJGP LIFE
  • MORE
    • About BJGP
    • Conference
    • Advertising
    • eLetters
    • Alerts
    • Video
    • Audio
    • Librarian information
    • Resilience
    • COVID-19 Clinical Solutions
  • RCGP
    • BJGP for RCGP members
    • BJGP Open
    • RCGP eLearning
    • InnovAIT Journal
    • Jobs and careers

User menu

  • Subscriptions
  • Alerts
  • Log in

Search

  • Advanced search
British Journal of General Practice
Intended for Healthcare Professionals
  • RCGP
    • BJGP for RCGP members
    • BJGP Open
    • RCGP eLearning
    • InnovAIT Journal
    • Jobs and careers
  • Subscriptions
  • Alerts
  • Log in
  • Follow bjgp on Twitter
  • Visit bjgp on Facebook
  • Blog
  • Listen to BJGP podcast
  • Subscribe BJGP on YouTube
British Journal of General Practice
Intended for Healthcare Professionals

Advanced Search

  • HOME
  • ONLINE FIRST
  • CURRENT ISSUE
  • ALL ISSUES
  • AUTHORS & REVIEWERS
  • SUBSCRIBE
  • BJGP LIFE
  • MORE
    • About BJGP
    • Conference
    • Advertising
    • eLetters
    • Alerts
    • Video
    • Audio
    • Librarian information
    • Resilience
    • COVID-19 Clinical Solutions
Editorials

Women’s health matters

Anne Connolly and Dame Lesley Regan
British Journal of General Practice 2022; 72 (725): 556-557. DOI: https://doi.org/10.3399/bjgp22X721193
Anne Connolly
Bevan Healthcare, Bradford; Chair of Primary Care, Primary Care Women’s Health Forum.
Roles: GP with a special interest in gynaecology
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Dame Lesley Regan
Imperial College at St Mary’s Hospital, London; Women’s Health Ambassador for England, Department of Health and Social Care, UK Government.
Roles: Professor and Head of Obstetrics and Gynaecology
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Info
  • eLetters
  • PDF
Loading

There has never been a better time for women’s health in the UK. The ‘strategies’,1 ‘plans’,2 and ambitions of the devolved nations’ governments have promised to reduce the inequalities that women experience.

This editorial uses the phrase ‘women’ throughout. This is not aimed at being exclusive but is inclusive of the trans population, recognising that not all those born with female reproductive organs identify as a woman and not all women have female reproductive organs.

CASE FOR CHANGE

For too long the physical, psychological, and social wellbeing of women has been compromised because of periods, pregnancy, or menopause. For too long research has been focused on male physiology and anatomy forgetting that, as quoted by Caroline Criado Perez in her book, Invisible Women. Exposing Data Bias in a World Designed for Men, that ‘women are not, to state the obvious, just men’. And for too long women of colour have been compromised more than others, creating a further inequality within an existing inequality.3,4

The disproportionate impact of the wider social determinants of health on women is also undervalued, requiring system- wide change from social care, employers, voluntary sector, and the public if women’s health and wellbeing is to improve.

There are many reasons that a spotlight on women is essential:

  • women in the UK live longer than men but spend longer in ill health and disability;5

  • women represent 51% of the UK population and 49% of the workforce, and undertake the vast majority of unpaid caring roles in society;6,7 and

  • there is a lack of data and evidence about conditions only affecting women, and those conditions affecting both men and women but exerting their impact in different ways, leading to missed symptoms and late presentations.

For those of us working at the frontline of health care trying to provide a holistic, life course approach, it is painfully evident that the current system of episodic care, inadequate women’s health information, and siloed commissioning consistently fails women; particularly those who find the system- wide barriers particularly hard to navigate. Some gynaecological conditions, including endometriosis, polycystic ovary syndrome, and premature ovarian insufficiency, require a long-term condition management approach. They should receive the same parity of esteem as other long- term conditions rewarded for management in primary care. Many women suffer with menstrual problems, tolerating them far too long because of the stigma associated with discussing ‘period problems’, not knowing what ‘normal’ is. An estimated 50% of pregnancies are unplanned,8 with an increasing number of women requesting abortion.9 Many perimenopausal women suffer unnecessarily in the workplace and feel forced to give up their careers or reduce their working commitments and ambitions.

Women’s health care would also benefit from focusing on prevention and early intervention to optimise preconceptual health and wellbeing to improve pregnancy outcomes, reduce the impact of common menstrual disorders by easier access to intra-uterine system insertions, improve gynaecological cancer outcomes by prevention, screening, and earlier diagnoses, and optimise long-term health in the post- reproductive phase of their lives.

THE WOMEN’S HEALTH STRATEGY FOR ENGLAND

The wide-ranging ambitions of the Women’s Health Strategy for England, published in July 2022, aims to improve women’s health care. The strategy recommendations were informed by a survey of nearly 100 000 women.10 Women said that they do not feel adequately supported in every aspect of their health and wellbeing, which included accessing high- quality information on women’s health issues, being dismissed by healthcare professionals, and feeling unsupported in their workplace.

The priority areas identified by women as problematic are ranked in order of importance by their responses to the survey:

  • menstrual health and gynaecological conditions;

  • fertility, pregnancy, pregnancy loss, and postnatal support;

  • menopause;

  • mental health and wellbeing;

  • cancers;

  • health impacts of violence against women and girls; and

  • healthy ageing and long-term conditions.

MAKING THIS WORK

The appointment of the Women’s Health Ambassador, Dame Lesley Regan, has been well received by the health community. Regan is supporting the policy team at the Department of Health and Social Care to deliver the ambitions of the Women’s Health Strategy by:

  • ensuring women’s voices are central to developments;

  • improving information and awareness;

  • optimising access to streamlined care delivery;

  • reducing disparities in health outcomes between women;

  • supporting women in the workplace;

  • developing education and training for health and care professionals;

  • increasing opportunities for research and evidence; and

  • ensuring improved data and digital access to information is available to all women.

The 2022 strategy calls for ‘women’s health hubs’ — the provision of intermediate holistic ‘one-stop’ care, as recommended in the Royal College of Obstetricians and Gynaecologists Better for Women report of 2019.11

These ‘hubs’ do not need to be new builds, or even physical clinics in a specific geographical location. They may be virtual advice centres where women can be reviewed, triaged, and signposted to appropriate services to meet their individual needs. Hybrid models will need to be developed, dependent on local need and informed by public health data metrics and the availability of clinical expertise.

In England, the recent introduction of integrated care systems (ICS) provides the ideal opportunity to build healthcare provision around the specific needs and priorities of local populations. By developing co-commissioning arrangements between health and social care sectors, women’s health hubs can provide one-stop services for menstrual disorders, long-acting reversible contraception, fitting vaginal ring-pessaries, and management of menopause symptoms. These services would be similar to those provided for long-term conditions, such as diabetes, traditionally provided in secondary care but with appropriate training and locally agreed pathways are now provided in ‘out- of-hospital’ settings by multidisciplinary teams.12

The Primary Care Women’s Health Forum women’s health hub toolkit contains many resources and examples to support clinicians and commissioners to consider the opportunities to develop local care.13 But to make this work it requires:

  • prioritisation at ICS level: commitment from NHS and local authority commissioners to work together and improve services for women;

  • review of funding pathways: maximising financial efficiencies by providing one-stop care in out-of-hospital settings;

  • ensuring the multidisciplinary workforce are performing optimally by developing affordable, accessible, modular training packages appropriate for local needs;

  • system-wide working: recognition of the impact of poverty, unemployment, and wider social determinants of disease exerted on women’s health and wellbeing; and

  • engaging the voluntary sector and using co-production to reduce inequalities by ensuring the care delivered is fit for purpose within the local community.14

CONCLUSION

The current government interest in women’s health care provides us with a unique opportunity to improve the care that women receive at every point across their life course. Realising this ambition will significantly reduce the inequalities that women currently experience when trying to access health care. Women are increasingly asking for advice and help with health concerns and symptoms that disturb or debilitate their day- to-day lives. They may have tolerated their problems for a long time, but only now feel empowered to talk about them following the positive media attention that menopause has received.

There will be no additional funding made available or reduction in workload to manage and implement the recommendations of the Women’s Health Strategy. Nevertheless, there are many opportunities to improve efficiency by providing the life course holistic care that women want and need, preferably in a single episode or visit, thereby allowing women to get on with their education, employment, or caring responsibilities

As Dame Lesley Regan says, ‘when we get it right for women, everyone in our society benefits’.

Notes

Provenance

Commissioned; not externally peer reviewed.

Competing interests

Anne Connolly has been paid by pharma for consultancy and providing education in women’s health. Further details of declarations can be found at: www.whopaysthisdoctor.org. Dame Lesley Regan has declared no competing interests.

  • © British Journal of General Practice 2022

REFERENCES

  1. 1.↵
    1. Department of Health and Social Care
    (2022) Women’s Health Strategy for England, https://www.gov.uk/government/publications/womens-health-strategy-for-england/womens-health-strategy-for-england (accessed 10 Nov 2022).
  2. 2.↵
    1. Scottish Government
    (2021) Women’s Health Plan: a plan for 2021–2024, https://www.gov.scot/publications/womens-health-plan (accessed 10 Nov 2022).
  3. 3.↵
    1. Draper ES,
    2. Gallimore ID,
    3. Smith LK,
    4. et al.
    (2022) MBRRACE-UK Perinatal Mortality Surveillance Report: UK perinatal deaths for births from January to December 2020, https://www.npeu.ox.ac.uk/assets/downloads/mbrrace-uk/reports/perinatal-surveillance-report-2020/MBRRACE-UK_Perinatal_Surveillance_Report_2020.pdf (accessed 10 Nov 2022).
  4. 4.↵
    1. Moser K,
    2. Patrick J,
    3. Beral V
    (2009) Inequalities in reported use of breast and cervical screening in Great Britain: analysis of cross sectional survey data. BMJ 338, b2025.
    OpenUrlAbstract/FREE Full Text
  5. 5.↵
    1. Office for National Statistics
    (2022) Health state life expectancies, UK: 2018 to 2022, https://www.ons.gov.uk/peoplepopulationandcommunity/healthandsocialcare/healthandlifeexpectancies/bulletins/healthstatelifeexpectanciesuk/2018to2020 (accessed 10 Nov 2022).
  6. 6.↵
    1. Department of Health
    (2015) Annual report of the Chief Medical Officer, 2014 The health of the 51%: women, https://assets.publishing.service.gov.uk/government/uploads/system/uploads/attachment_data/file/595439/CMO_annual_report_2014.pdf (accessed 10 Nov 2022).
  7. 7.↵
    1. Irvine S,
    2. Clark H,
    3. Ward M,
    4. Francis-Devine B
    (2022) Women and the UK economy, https://researchbriefings.files.parliament.uk/documents/SN06838/SN06838.pdf (accessed 11 Nov 2022).
  8. 8.↵
    1. Wellings K,
    2. Jones KG,
    3. Mercer CH,
    4. et al.
    (2013) The prevalence of unplanned pregnancy and associated factors in Britain: findings from the third National Survey of Sexual Attitudes and Lifestyles (Natsal-3). Lancet 382, 9907, 1807–1816.
    OpenUrlCrossRefPubMed
  9. 9.↵
    1. Office for Health Information and Disparities
    (2022) Abortion statistics, England and Wales 2021, https://www.gov.uk/government/statistics/abortion-statistics-for-england-and-wales-2021/abortion-statistics-england-and-wales-2021 (accessed 10 Nov 2022).
  10. 10.↵
    1. Department of Health and Social Care
    (2022) Women’s Health Strategy: call for evidence. https://www.gov.uk/government/consultations/womens-health-strategy-call-for-evidence (accessed 10 Nov 2022).
  11. 11.↵
    1. Royal College of Obstetricians and Gynaecologists
    (2019) Better for women: improving the health and wellbeing of girls and women, https://www.rcog.org.uk/media/h3smwohw/better-for-women-full-report.pdf (accessed 10 Nov 2022).
  12. 12.↵
    1. Unadkat N,
    2. Evans L,
    3. Nasir L,
    4. et al.
    (2013) Taking diabetes services out of hospital into the community. London J Prim Care (Abingdon) 5, 2, 65–69.
    OpenUrl
  13. 13.↵
    1. Primary Care Women’s Health Forum
    2021 Women’s health hub toolkit. https://whh.pcwhf.co.uk (accessed 10 Nov 2022).
  14. 14.↵
    1. Craddock E
    An evaluation of the Women’s Health Network (WHN) in Bradford, https://bcuassets.blob.core.windows.net/docs/whn-report-final-bcu-version-090322-132913779792459389.pdf (accessed 10 Nov 2022).
Back to top
Previous ArticleNext Article

In this issue

British Journal of General Practice: 72 (725)
British Journal of General Practice
Vol. 72, Issue 725
December 2022
  • Table of Contents
  • Index by author
Download PDF
Article Alerts
Or,
sign in or create an account with your email address
Email Article

Thank you for recommending British Journal of General Practice.

NOTE: We only request your email address so that the person to whom you are recommending the page knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
Women’s health matters
(Your Name) has forwarded a page to you from British Journal of General Practice
(Your Name) thought you would like to see this page from British Journal of General Practice.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Citation Tools
Women’s health matters
Anne Connolly, Dame Lesley Regan
British Journal of General Practice 2022; 72 (725): 556-557. DOI: 10.3399/bjgp22X721193

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero

Share
Women’s health matters
Anne Connolly, Dame Lesley Regan
British Journal of General Practice 2022; 72 (725): 556-557. DOI: 10.3399/bjgp22X721193
del.icio.us logo Digg logo Reddit logo Twitter logo CiteULike logo Facebook logo Google logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One
  • Mendeley logo Mendeley

Jump to section

  • Top
  • Article
    • CASE FOR CHANGE
    • THE WOMEN’S HEALTH STRATEGY FOR ENGLAND
    • MAKING THIS WORK
    • CONCLUSION
    • Notes
    • REFERENCES
  • Info
  • eLetters
  • PDF

More in this TOC Section

  • Socioeconomic deprivation and post-stroke care in the community
  • Advocating for patients through laboratory tests: what do GPs’ use of blood tests for suspected cancer tell us?
  • Diagnosis of prostate cancer in primary care: navigating updated clinical guidance
Show more Editorials

Related Articles

Cited By...

Intended for Healthcare Professionals

BJGP Life

BJGP Open

 

@BJGPjournal's Likes on Twitter

 
 

British Journal of General Practice

NAVIGATE

  • Home
  • Current Issue
  • All Issues
  • Online First
  • Authors & reviewers

RCGP

  • BJGP for RCGP members
  • BJGP Open
  • RCGP eLearning
  • InnovAiT Journal
  • Jobs and careers

MY ACCOUNT

  • RCGP members' login
  • Subscriber login
  • Activate subscription
  • Terms and conditions

NEWS AND UPDATES

  • About BJGP
  • Alerts
  • RSS feeds
  • Facebook
  • Twitter

AUTHORS & REVIEWERS

  • Submit an article
  • Writing for BJGP: research
  • Writing for BJGP: other sections
  • BJGP editorial process & policies
  • BJGP ethical guidelines
  • Peer review for BJGP

CUSTOMER SERVICES

  • Advertising
  • Contact subscription agent
  • Copyright
  • Librarian information

CONTRIBUTE

  • BJGP Life
  • eLetters
  • Feedback

CONTACT US

BJGP Journal Office
RCGP
30 Euston Square
London NW1 2FB
Tel: +44 (0)20 3188 7400
Email: journal@rcgp.org.uk

British Journal of General Practice is an editorially-independent publication of the Royal College of General Practitioners
© 2023 British Journal of General Practice

Print ISSN: 0960-1643
Online ISSN: 1478-5242